Growth inhibitory effect of 4-hydroxy-tamoxifen on the BT-20 mammary cancer cell line

This publication has 10 references indexed in Scilit:

• New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen
  Biochemical and Biophysical Research Communications, 1986
• Catecholestrogen binding sites in breast cancer
  The Journal of Steroid Biochemistry and Molecular Biology, 1985
• An Evaluation of the Role of Antiestrogen-Binding Sites in Mediating the Growth Modulatory Effects of Antiestrogens: Studies Usingt-Butylphenoxyethyl Diethylamine, a Compound Lacking Affinity for the Estrogen Receptor*
  Endocrinology, 1985
• High affinity cytosol binding site(S) for antiestrogens in two human breast cancer cell lines and in biopsy specimens devoid of estrogen receptors
  The Journal of Steroid Biochemistry and Molecular Biology, 1984
• The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor
  Molecular and Cellular Endocrinology, 1984
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
  Biochemical and Biophysical Research Communications, 1984
• Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13
  Cancer Chemotherapy and Pharmacology, 1983
• High-affinity anti-oestrogen binding site distinct from the oestrogen receptor
  Nature, 1980
• Improvements in the ethidium bromide method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenates
  Analytical Biochemistry, 1977
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971